ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK..HRIS..............................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/0200909181922061CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120100908W154deBibliographieenBibliographyfrBibliographieEP06761981.72006060720071214enenen15145920050614US2010090820103620080521200821200812172008512008071720090317BG20081217CZ20081217EE20081217FI20090417IS20081217LT20081217LV20081217PL20081217RO20081217SI20081217SK20100908201036A61K 9/16 20060101AFI20080131BHEP A61K 31/4439 20060101ALI20080131BHEP deFESTE ORALE DARREICHUNGSFORM DES TUBULINHEMMSTOFFS INDIBULINenORAL SOLID PHARMACEUTICAL FORMULATION OF THE TUBULIN INHIBITOR INDIBULINfrFORMULATION SOLIDE PHARMACEUTIQUE ORALE DU COMPOSE INDIBULINE INHIBITEUR DE LA TUBULINEWO-A-03/037861WO-A-2006/052712WO-A1-2006/002887ROESSLER, BertholdKluskamp 333790 HalleDERAAB, GerhardBirkenstrasse 76a63549 RonneburgDEREISSMANN, ThomasRettmers Hoehe 4321335 LueneburgDEZIOPHARM ONCOLOGY, INC.101004532N3400 EPOne First Avenue Parris Building No. 34 Navy Yard PlazaBoston, MA 02129USHock, Joachim100046843Müller-Boré & Partner Grafinger Strasse 281671 MünchenDEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCNLPLPTROSESISKTRHR20071214EP200600542320060607enWO200613383520061221200651